Related Experiment Video
Updated: May 22, 2025
02:47
Author Spotlight: Exercise Test for Evaluation of the Functional Efficacy of the Pig Cardiovascular System
Published on: May 12, 2023
1.3K
Advancing surgical outcomes through cardiovascular biomarker sub-phenotyping
Bruno Garcia1, Ashish K Khanna2, Matthieu Legrand3
1Department of Intensive Care, Centre Hospitalier Universitaire de Lille, Lille, France.
British Journal of Anaesthesia
|March 15, 2025
Summary
Researchers identified patient sub-phenotypes using biomarkers like N-terminal pro-brain natriuretic peptide, associated with varied risks of postoperative myocardial injury after noncardiac surgery.
Area of Science:
- Cardiology
- Perioperative Medicine
- Biomarker Research
Background:
- Postoperative myocardial injury (PMI) is a significant complication after major noncardiac surgery.
- Identifying patients at high risk for PMI is crucial for improving outcomes.
- Current risk stratification methods may not capture the full complexity of patient responses.
Related Concept Videos
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
76
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
76
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
40
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
40